{
    "nctId": "NCT03314870",
    "briefTitle": "Development of a Response Signature to Neoadjuvant Chemotherapy for Breast Cancer",
    "officialTitle": "Development of a Response Signature to Neoadjuvant Chemotherapy for Breast",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 220,
    "primaryOutcomeMeasure": "The number of molecular signatures predictive of response to neoadjuvant chemotherapy which would be able to discriminate between patient groups based on their epithelio-mesenchymal transition status and their immune status.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women and men with breast cancer\n* Treated with neoadjuvant chemotherapy\n\nExclusion Criteria:\n\n* None",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}